Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56

NCT01235351 is registered in ClinicalTrials.gov with The TIMI Study Group as lead sponsor.

NCT NCT01235351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01235351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56
Lead sponsor
The TIMI Study Group
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2010
Completion date
September 30, 2011
Enrollment
335 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction, percutaneous coronary intervention